M Plauth

Summary

Country: Germany

Publications

  1. doi request reprint [Nutrition and liver failure]
    M Plauth
    Klinik fur Innere Medizin, Städtisches Klinikum Dessau, Auenweg 38, 06847, Dessau, Deutschland
    Med Klin Intensivmed Notfmed 108:391-5. 2013
  2. pmc Bioelectrical impedance analysis in clinical practice: implications for hepatitis C therapy BIA and hepatitis C
    Alisan Kahraman
    University Clinic Duisburg Essen, Department of Gastroenterolgy and Hepatology, Essen, Germany
    Virol J 7:191. 2010
  3. doi request reprint Branched-chain amino acids in liver disease: new aspects of long known phenomena
    Mathias Plauth
    Klinik fur Innere Medizin, Städtisches Klinikum Dessau, Dessau, Germany
    Curr Opin Clin Nutr Metab Care 14:61-6. 2011
  4. ncbi request reprint Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism
    Mathias Plauth
    Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, Charite Universitatsmedizin Berlin, Berlin, Germany
    J Hepatol 40:228-33. 2004
  5. ncbi request reprint ESPEN Guidelines on Enteral Nutrition: Liver disease
    M Plauth
    Department Internal Medicine, Staedtisches Klinikum, Dessau, Germany
    Clin Nutr 25:285-94. 2006
  6. ncbi request reprint [Branched chain amino acids as oral supplements in liver cirrhosis]
    M Plauth
    Klinik fur Innere Medizin, Städtisches Klinikum Dessau
    Z Gastroenterol 44:207-8. 2006
  7. ncbi request reprint Controlled clinical trial of doxorubicin and tamoxifen versus tamoxifen monotherapy in hepatocellular carcinoma
    G Schachschal
    Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, Humboldt Universitat zu Berlin, Germany
    Eur J Gastroenterol Hepatol 12:281-4. 2000
  8. ncbi request reprint Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents
    J Ockenga
    Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, Charite Universitatsmedizin Berlin, Germany
    Scand J Gastroenterol 39:994-9. 2004
  9. ncbi request reprint Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI
    H Lochs
    IV Medizinische Klinik, Universitatsklinikum Charite, Humboldt Universitat, Berlin, Germany
    Gastroenterology 118:264-73. 2000
  10. doi request reprint ESPEN Guidelines on Parenteral Nutrition: hepatology
    Mathias Plauth
    Städtisches Klinikum, Dessau, Germany
    Clin Nutr 28:436-44. 2009

Detail Information

Publications13

  1. doi request reprint [Nutrition and liver failure]
    M Plauth
    Klinik fur Innere Medizin, Städtisches Klinikum Dessau, Auenweg 38, 06847, Dessau, Deutschland
    Med Klin Intensivmed Notfmed 108:391-5. 2013
    ..Enteral nutrition ensuring an adequate provision of energy and protein should be preferred. Particular care should be taken to avoid refeeding syndrome and to treat vitamin and trace element deficiency...
  2. pmc Bioelectrical impedance analysis in clinical practice: implications for hepatitis C therapy BIA and hepatitis C
    Alisan Kahraman
    University Clinic Duisburg Essen, Department of Gastroenterolgy and Hepatology, Essen, Germany
    Virol J 7:191. 2010
    ..Objective of this prospective study was to investigate clinical use and prognostic value of BIA-derived phase angle and alterations in body composition for hepatitis C infection (HCV) following antiviral therapy...
  3. doi request reprint Branched-chain amino acids in liver disease: new aspects of long known phenomena
    Mathias Plauth
    Klinik fur Innere Medizin, Städtisches Klinikum Dessau, Dessau, Germany
    Curr Opin Clin Nutr Metab Care 14:61-6. 2011
    ....
  4. ncbi request reprint Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism
    Mathias Plauth
    Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, Charite Universitatsmedizin Berlin, Berlin, Germany
    J Hepatol 40:228-33. 2004
    ..To search for changes in body composition and energy metabolism associated with the repeatedly observed weight gain of cirrhotic patients after portosystemic shunting...
  5. ncbi request reprint ESPEN Guidelines on Enteral Nutrition: Liver disease
    M Plauth
    Department Internal Medicine, Staedtisches Klinikum, Dessau, Germany
    Clin Nutr 25:285-94. 2006
    ..TF commenced early after liver transplantation can reduce complication rate and cost and is preferable to parenteral nutrition. In acute liver failure TF is feasible and used in the majority of patients...
  6. ncbi request reprint [Branched chain amino acids as oral supplements in liver cirrhosis]
    M Plauth
    Klinik fur Innere Medizin, Städtisches Klinikum Dessau
    Z Gastroenterol 44:207-8. 2006
  7. ncbi request reprint Controlled clinical trial of doxorubicin and tamoxifen versus tamoxifen monotherapy in hepatocellular carcinoma
    G Schachschal
    Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, Humboldt Universitat zu Berlin, Germany
    Eur J Gastroenterol Hepatol 12:281-4. 2000
    ..Oral tamoxifen has been proposed on the basis of beneficial results in some trials. The aim of this study was to evaluate whether the addition of doxorubicin to oral tamoxifen improves survival compared to oral tamoxifen alone...
  8. ncbi request reprint Covered transjugular intrahepatic portosystemic stents maintain lower portal pressure and require fewer reinterventions than uncovered stents
    J Ockenga
    Medizinische Klinik mit Schwerpunkt Gastroenterologie, Hepatologie und Endokrinologie, Charite Universitatsmedizin Berlin, Germany
    Scand J Gastroenterol 39:994-9. 2004
    ..The purpose of this study was to evaluate the patency, functional and haemodynamic results of expanded-polytetrafluoroethylene (ePTFE)-covered transjugular intrahepatic portosystemic shunts in patients with liver cirrhosis...
  9. ncbi request reprint Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI
    H Lochs
    IV Medizinische Klinik, Universitatsklinikum Charite, Humboldt Universitat, Berlin, Germany
    Gastroenterology 118:264-73. 2000
    ..This study investigated if long-term treatment with high-dose mesalamine reduces the risk of clinical relapse of Crohn's disease after surgical resection...
  10. doi request reprint ESPEN Guidelines on Parenteral Nutrition: hepatology
    Mathias Plauth
    Städtisches Klinikum, Dessau, Germany
    Clin Nutr 28:436-44. 2009
    ..Perioperative (including liver transplantation) PN is safe and reduces the rate of complications. In acute liver failure PN is a safe second-line option to adequately feed patients in whom enteral nutrition is insufficient or impossible...
  11. ncbi request reprint Cachexia in liver cirrhosis
    Mathias Plauth
    Klinik fur Innere Medizin, Städtisches Klinikum, Auenweg 38, 06847 Dessau, Germany
    Int J Cardiol 85:83-7. 2002
    ....
  12. ncbi request reprint Clinical practice of nutrition in acute liver failure--a European survey
    Tatjana Schütz
    Medizinische Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Charite Universitatsmedizin, Campus Charite Mitte, Berlin 10098, Germany
    Clin Nutr 23:975-82. 2004
    ..Evidence-based guidelines for artificial nutrition in hyperacute (HLF), acute (ALF) and subacute liver failure (SLF) cannot be given at present due to scarcity of clinical studies...
  13. ncbi request reprint Ammonia metabolism in cirrhotic patients with TIPS
    Mathias Plauth
    Hepatology 37:1496-7; author reply 1497. 2003